06
May
India Emerging as Major Market for Biosimilar Immunotherapy, But Patient Awareness Still Lags: Oncologists
India is emerging as a major market for biosimilar immunotherapy, making advanced cancer treatment more affordable and accessible. However, oncologists warn that low patient awareness and delayed diagnosis continue to limit the benefits of these therapies.





